Advertisement

Reflections of the Role of Adrenergic Mechanisms in Ventricular Arrhythmias

  • I. J. Kopin
Conference paper

Abstract

Electrophysiological and pathological data presented in Chapter III of this book show that surviving myocardial cells at the margins, endothelial or epicardial surfaces of an infarcted area may be of etiological importance in the development of arrhythmias. Alterations in their rates and pathways of depolarization and repolarization and of their effective refractory periods are important factors in generating ventricular arrhythmias. In abnormal myocardium, enhanced automaticity and/or myocardial conduction abnormalities produce depolarizing selfperpetuating rapid circuits with reentry of waves of depolarization producing contractions. Waves of depolarization arising from a single (or a few) abnormal site(s) result in one or more ventricular extrasystoles. Ventricular tachycardia is a sustained rapid series of such ventricular contractions; ejection of ventricular contents maintains, to some extent, the circulation of blood. Ventricular tachycardia may degenerate into ventricular fibrillation. Indeed, it appears from the results reported by Dr. Scherlag that a short series of three to four ventricular tachycardia-like beats (triplets or quadruplets) often initiates ventricular fibrillation. In ventricular fibrillation, chaotic multifocal depolarization waves make effective ventricular contraction impossible; there is complete disruption of cardiac function, failure of ventricular ejection of blood, and sudden death.

Keywords

Ventricular Arrhythmia Ventricular Fibrillation Norepinephrine Release Catecholamine Release Sympathetic Nerve Terminal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Knight DE, Baker PF (1986) Exocytosis from the vesicle viewpoint: an overview. Ann NY Acad Sci 493:504–523.CrossRefGoogle Scholar
  2. 2.
    Knight DE (1986) Calcium and exocytosis. Ciba Found Symp 122:250–270.PubMedGoogle Scholar
  3. 3.
    Bönisch H, Fuchs G, Graefe KH (1986) Sodium-dependence of the saturability of carriermediated noradrenaline efflux fro noradrenergic neurons in the rat vas deferens. Naunyn-Schmiedebergs Arch Pharmacol 332:131–134.PubMedCrossRefGoogle Scholar
  4. 4.
    Carlsson L, Graefe KH, Trendelenburg U (1987) Early intraneuronal mobilization an deamination of noradrenaline during global ischemia in the isolated perfused rat heart. Naunyn-Schmiedebergs Arch Pharmacol 336:508–518.PubMedGoogle Scholar
  5. 5.
    Olasmaa M, Terenius L (1986) Neuropeptide Y receptor interaction with beta-adrenoceptor coupling to adenylate cyclase. Prog Brain Res 68:337–341.PubMedCrossRefGoogle Scholar
  6. 6.
    Samet MK, Rutledge CO (1977) Antagonism of the positive chronotropic effect of norepinephrine by purine nucleosides in rat atria. J Pharmacol Exp Ther 232:106–110.Google Scholar
  7. 7.
    Richardt G, Waas W, Kranzhöfer R, Mayer E, Schömig A (1987) Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circ Res 61:117–123.PubMedGoogle Scholar
  8. 8.
    Christensen NJ, Videback J (1985) Plasma catecholamines and carbohydrate metabolism in patients with myocardial infarction. J Clin Invest 54:278–286.CrossRefGoogle Scholar
  9. 9.
    Karlsberg RP, Cryer PE, Roberts R (1981) Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 102:27–31.CrossRefGoogle Scholar
  10. 10.
    Bertel O, Buhler FR, Baitsch G, Ritz R, Burkart F (1982) Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severity. Chest 82:64–68.PubMedCrossRefGoogle Scholar
  11. 11.
    Dart AM, Riemersma RA, Schömig A, Ungar A (1987) Metabolic requirements for release of endogenous noradrenaline during myocardial ischemia and anoxia. Br J Pharmacol 90:43–50.PubMedGoogle Scholar
  12. 12.
    Schwartz PF, Stone HL (1980) Left stellatectomy in the prevention of ventricular fibrillation due to acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 62:1256–1265.PubMedGoogle Scholar
  13. 13.
    Dart AM, Dietz R, Hieronymus K, Kübler W, Mayer E, Schömig A, Strasser R (1984) Effects of alpha-and beta-adrenoceptor blockade on the neurally evoked overflow of endogenous noradrenaline from the rat isolated heart. Br J Pharmacol 81:475–478.PubMedGoogle Scholar
  14. 14.
    Schömig A, Dart AM, Dietz R, Mayer E, Kübler W (1984) Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A. Locally mediated release. Circ Res 55:689–701.PubMedGoogle Scholar
  15. 15.
    Schömig A, Dart AM, Dietz R, Kübler W, Mayer E (1985) Paradoxical role of neuronal uptake for the locally mediated release of endogenous noradrenaline in the ischemic myocardium. J Cardiovasc Pharmacol 7 (Suppl 5):S40–S440.PubMedCrossRefGoogle Scholar
  16. 16.
    Schömig A, Fischer S, Kurz T, Richardt G, Schömig E (1987) Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ Res 60:194–205.PubMedGoogle Scholar
  17. 17.
    Kübler W, Schömig A, Senges J (1985) The conduction and cardiac sympathetic systems: metabolic aspects. J Am Coll Cardiol 5 (Suppl 6):157B–161B.PubMedCrossRefGoogle Scholar
  18. 18.
    Langer SZ (1966) The degeneration contraction of the nictitating membrane in the unanesthetized cat. J Pharmacol Exp Ther 151:66–72.PubMedGoogle Scholar
  19. 19.
    Barber MJ, Mueller TM, Henry DP, Feltan SY, Zipes DP (1983) Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67:787–796.PubMedCrossRefGoogle Scholar
  20. 20.
    Langer SZ, Trendelenburg U (1966) The onset of denervation supersensitivity. J Pharmacol Exp Ther 151:73–86.PubMedGoogle Scholar
  21. 21.
    Kammerling JJ, Green FJ, Watanabe AM, Inoue H, Barber MJ, Henry DP, Zipes DP (1987) Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 76:383–393.PubMedCrossRefGoogle Scholar
  22. 22.
    Inoue H, Zipes DP (1987) Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic. Circulation 75:877–887.PubMedCrossRefGoogle Scholar
  23. 23.
    Maisel AS, Motulsky HJ, Insel PA (1985) Externalization of β-adrenergic receptors by myocardial ischemia. Science 230:183–386.PubMedCrossRefGoogle Scholar
  24. 24.
    Reuter H, Cachelin AB, DePeyer JE, Kokubun S (1983) Modulation of calcium channels in cultured cardiac cells by isoprotereol and 8-bromo-cAMP. Cold Spring Harbour Symp Quant Biol 48:193–200.Google Scholar
  25. 25.
    Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, Howycky MC (1986) Mechanisms of calcium channel modulation by β-adrenergic agents and dihydropyridine calcium antagonists. J Mol Cell Cardiol 18:691–710.PubMedCrossRefGoogle Scholar
  26. 26.
    Curtis BM, Catterall WA (1985) Phosphorylation of the calcium antagonist receptor of the voltage sensitive calcium channel by cAMP dependent protein kinase. Proc Natl Acad Sci USA 82:2528.PubMedCrossRefGoogle Scholar
  27. 27.
    Porzig H (1987) Catecholamine-induced changes in plasma membrane biochemistry and function. Med Res Rev 7:183–226.PubMedCrossRefGoogle Scholar
  28. 28.
    Pieper GM, Todd GL, Wu ST, Sachany JM, Glayton FC, Eliot RS (1980) Attenuation of myocardial acidosis by propronolol during ischemic arrest and reperfusion: evidence with 31P nuclear magnetic resonance. Cardiovasc Res 14:646–653.PubMedCrossRefGoogle Scholar
  29. 29.
    Isumi T, Sakai K, Akibo Y (1982) Effect of Sotalol on ischemic myocardial pH in the dog heart. Naunyn-Schmiedebergs Arch Pharmacol 318:340–343.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • I. J. Kopin

There are no affiliations available

Personalised recommendations